Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An Optimization Framework to Study the Balance Between Expected Fatalities due to COVID-19 and the Reopening of U.S. Communities

View ORCID ProfileVictoria C. P. Chen, View ORCID ProfileYuan Zhou, Alireza Fallahi, Amith Viswanatha, Jingmei Yang, Yasaman Ghasemi, Nilabh. S. Ohol, View ORCID ProfileJay M. Rosenberger, Feng Liu, Xinglong Ju, Jeffrey B. Guild
doi: https://doi.org/10.1101/2020.07.16.20152033
Victoria C. P. Chen
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victoria C. P. Chen
  • For correspondence: vchen{at}uta.edu
Yuan Zhou
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuan Zhou
Alireza Fallahi
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amith Viswanatha
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingmei Yang
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasaman Ghasemi
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilabh. S. Ohol
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay M. Rosenberger
1Center on Stochastic Modeling, Optimization, & Statistics (COSMOS), Department of Industrial, Manufacturing, and Systems Engineering, The University of Texas at Arlington, Arlington, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jay M. Rosenberger
Feng Liu
2Department of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.A.
3Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinglong Ju
4Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey B. Guild
5Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

As communities reopen following shelter-in-place orders, they are facing two conflicting objectives. The first is to keep the COVID-19 fatality rate down. The second is to revive the U.S. economy and the livelihood of millions of Americans. In this paper, a team of researchers from the Center on Stochastic Modeling, Optimization, & Statistics (COSMOS) at the University of Texas at Arlington, in collaboration with researchers from University of Texas Southwestern Medical Center and Harvard Medical School, has formulated a computationally-efficient optimization framework, referred to as COSMOS COVID-19 Linear Programming (CC19LP), to study the delicate balance between the expected fatality rate and the level of normalcy in the community. Given the disproportionate fatality characteristics of COVID-19 among those in different age groups or with an underlying medical condition or those living with crowding, the key to the CC19LP framework is a focus on “key contacts” that separate individuals at higher risk from the rest of the population. The philosophy of CC19LP lies in maximizing protection of key contacts, so as to shield high-risk individuals from infection. Given the lack of pharmaceutical solutions, i.e., a vaccine or cure, the CC19LP framework minimizes expected fatalities by optimizing the use of non-pharmaceutical interventions, namely COVID-19 testing; personal protective equipment; and social precautions, such as distancing, hand-washing, and face coverings. Low-risk individuals that are not key contacts, including most children, are unrestricted and can choose to participate in pre-pandemic normal activities, which eliminates the need for compliance across the entire population. Consequently, the CC19LP framework demonstrates optimal strategies for protecting high-risk individuals while reopening communities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

N/A

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB not applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

An online tool for the optimization has been developed by the authors and is publicly available. Data on COVID-19 cases and fatalities were obtained from a publicly available website. Data for the optimization were generated via publicly available Census data and a Gallup poll.

https://cosmos.uta.edu/projects/covid-19/

https://ourworldindata.org/coronavirus

https://www.census.gov/data.html

https://news.gallup.com/poll/304643/million-severe-risk-infected-covid.aspx

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An Optimization Framework to Study the Balance Between Expected Fatalities due to COVID-19 and the Reopening of U.S. Communities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An Optimization Framework to Study the Balance Between Expected Fatalities due to COVID-19 and the Reopening of U.S. Communities
Victoria C. P. Chen, Yuan Zhou, Alireza Fallahi, Amith Viswanatha, Jingmei Yang, Yasaman Ghasemi, Nilabh. S. Ohol, Jay M. Rosenberger, Feng Liu, Xinglong Ju, Jeffrey B. Guild
medRxiv 2020.07.16.20152033; doi: https://doi.org/10.1101/2020.07.16.20152033
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An Optimization Framework to Study the Balance Between Expected Fatalities due to COVID-19 and the Reopening of U.S. Communities
Victoria C. P. Chen, Yuan Zhou, Alireza Fallahi, Amith Viswanatha, Jingmei Yang, Yasaman Ghasemi, Nilabh. S. Ohol, Jay M. Rosenberger, Feng Liu, Xinglong Ju, Jeffrey B. Guild
medRxiv 2020.07.16.20152033; doi: https://doi.org/10.1101/2020.07.16.20152033

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)